• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

交互式验证分析多种测序数据,以鉴定肺腺癌的潜在生物标志物。

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.

机构信息

Department of Reproductive Genetics, International Peace Maternity and Child Health Hospital, Shanghai Key Laboratory of Embryo Original Diseases, Shanghai Municipal Key Clinical Specialty, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.

出版信息

Biomed Res Int. 2020 Oct 1;2020:8931419. doi: 10.1155/2020/8931419. eCollection 2020.

DOI:10.1155/2020/8931419
PMID:33062704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7547331/
Abstract

BACKGROUND

Lung adenocarcinoma (LUAD) comprises around 40% of all lung cancers, and in about 70% of patients, it has spread locally or systemically when first detected leading to a worse prognosis.

METHODS

We filtered out differentially expressed genes (DEGs) based on the RNA sequencing data in the Gene Expression Omnibus database and verified and deeply analyzed screened DEGs using a combined bioinformatics approach.

RESULTS

Expressions of 11,143 genes in 694 nontumor lung tissues and LUAD cases from 8 independent laboratories were analyzed; 188 mRNAs were identified as differentially expressed genes (DEGs). A PPI network constructed with 188 DEGs screened out 8 hub DEGs (, , , , , , , and ) which highly interconnected with other nodes. The expression levels of 8 hub genes in LUAD and control were assessed in the Oncomine database, and the results were consistent. The survival curves of 8 hub genes showed that their expressions are significantly related to the prognosis of lung cancer and LUAD patients except for . Since the expression of is nonspecific and highly sensitive, we choose the other 7 hub genes we had verified to do the next analysis. Mutual exclusivity or cooccurrence analysis of 7 hub genes identified a tendency towards cooccurrence between , , and in LUAD. The coexpression profiles of in LUAD were identified, and we found that and coexpressed with CDH5. Immunohistochemistry and RT-PCR analysis showed that higher levels of , , and were expressed in normal lung tissues but a low or undetectable level was found in LUAD tissues.

CONCLUSIONS

Taken together, we speculate that , , and played an important role in LUAD.

摘要

背景

肺腺癌(LUAD)约占所有肺癌的 40%,约 70%的患者在首次发现时已局部或全身扩散,导致预后较差。

方法

我们根据 GEO 数据库中的 RNA 测序数据筛选差异表达基因(DEGs),并采用综合生物信息学方法对筛选出的 DEGs 进行验证和深入分析。

结果

分析了 8 个独立实验室的 694 例非肿瘤肺组织和 LUAD 病例中 11143 个基因的表达情况,筛选出 188 个差异表达基因(DEGs)。用 188 个 DEGs 构建的 PPI 网络筛选出 8 个核心 DEGs(,, , , , , 和 ),它们与其他节点高度连接。在 Oncomine 数据库中评估了 8 个核心基因在 LUAD 和对照中的表达水平,结果一致。8 个核心基因的生存曲线表明,它们的表达与肺癌和 LUAD 患者的预后显著相关,除了 。由于 的表达非特异性和高度敏感,我们选择了我们已经验证的其他 7 个核心基因进行下一步分析。7 个核心基因的互斥或共发生分析表明,在 LUAD 中存在 、 和 共发生的趋势。鉴定了 LUAD 中 7 个核心基因的共表达谱,发现 与 CDH5 共表达。免疫组化和 RT-PCR 分析显示,在正常肺组织中高表达 、 和 ,而在 LUAD 组织中低表达或检测不到。

结论

综上所述,我们推测 、 和 在 LUAD 中发挥了重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/39544ef3dd2a/BMRI2020-8931419.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/267c1192cfde/BMRI2020-8931419.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/cb96ccd8ae75/BMRI2020-8931419.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/ff2be8acd2bb/BMRI2020-8931419.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/0f846d099e2a/BMRI2020-8931419.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/3df638117492/BMRI2020-8931419.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/b10efbf648c9/BMRI2020-8931419.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/e31d99181fc3/BMRI2020-8931419.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/96b9f359ba79/BMRI2020-8931419.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/21cbf6889957/BMRI2020-8931419.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/39544ef3dd2a/BMRI2020-8931419.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/267c1192cfde/BMRI2020-8931419.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/cb96ccd8ae75/BMRI2020-8931419.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/ff2be8acd2bb/BMRI2020-8931419.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/0f846d099e2a/BMRI2020-8931419.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/3df638117492/BMRI2020-8931419.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/b10efbf648c9/BMRI2020-8931419.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/e31d99181fc3/BMRI2020-8931419.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/96b9f359ba79/BMRI2020-8931419.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/21cbf6889957/BMRI2020-8931419.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e249/7547331/39544ef3dd2a/BMRI2020-8931419.010.jpg

相似文献

1
Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.交互式验证分析多种测序数据,以鉴定肺腺癌的潜在生物标志物。
Biomed Res Int. 2020 Oct 1;2020:8931419. doi: 10.1155/2020/8931419. eCollection 2020.
2
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.与肺腺癌相关的候选诊断和预后生物标志物的综合分析。
Med Sci Monit. 2020 Jun 24;26:e922070. doi: 10.12659/MSM.922070.
3
Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.基于生物信息学分析的肺腺癌潜在预后生物标志物。
Biomed Res Int. 2021 Jan 14;2021:8859996. doi: 10.1155/2021/8859996. eCollection 2021.
4
The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.基于生物信息学的肺腺癌患者关键生物标志物的鉴定。
Math Biosci Eng. 2019 Aug 21;16(6):7671-7687. doi: 10.3934/mbe.2019384.
5
Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.基于生物信息学分析鉴定肺腺癌相关差异表达基因。
Gen Physiol Biophys. 2021 Jan;40(1):31-48. doi: 10.4149/gpb_2020037.
6
Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.免疫相关基因在快速复发早期肺腺癌中表达谱的基因芯片分析。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2299-2310. doi: 10.1007/s00432-020-03287-7. Epub 2020 Jun 18.
7
Identification of key genes associated with lung adenocarcinoma by bioinformatics analysis.基于生物信息学分析鉴定肺腺癌相关的关键基因。
Sci Prog. 2021 Jan-Mar;104(1):36850421997276. doi: 10.1177/0036850421997276.
8
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
9
High Expression of , , and Predicts Worse Prognosis among Nonsmoking Patients with Lung Adenocarcinoma through Bioinformatics Analysis.通过生物信息学分析, 、 、 在不吸烟肺腺癌患者中的高表达预示着更差的预后。
Biomed Res Int. 2020 Oct 20;2020:2071593. doi: 10.1155/2020/2071593. eCollection 2020.
10
Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.基于生物信息学分析鉴定 KIF4A 及其对肺腺癌进展的影响。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203973.

引用本文的文献

1
Bioinformatics-Based Discovery of Therapeutic Targets in Cadmium-Induced Lung Adenocarcinoma: The Role of Oxyresveratrol.基于生物信息学的镉诱导肺腺癌治疗靶点发现:氧化白藜芦醇的作用
Biol Trace Elem Res. 2025 Jul 4. doi: 10.1007/s12011-025-04730-x.
2
Bioinformatics-Driven Investigations of Signature Biomarkers for Triple-Negative Breast Cancer.生物信息学驱动的三阴性乳腺癌标志性生物标志物研究
Bioinform Biol Insights. 2025 Mar 2;19:11779322241271565. doi: 10.1177/11779322241271565. eCollection 2025.
3
An in-silico approach leads to explore six genes as a molecular signatures of lung adenocarcinoma.

本文引用的文献

1
Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application.肺癌表观遗传学的当前态势:聚焦机制与应用
J Oncol. 2019 Dec 12;2019:8107318. doi: 10.1155/2019/8107318. eCollection 2019.
2
A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.基于综合分析和加权基因共表达网络的腺癌型非小细胞肺癌患者生存的六基因签名预测:一项综合研究。
Biomed Res Int. 2019 Dec 4;2019:4250613. doi: 10.1155/2019/4250613. eCollection 2019.
3
Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.
一种计算机模拟方法用于探索六个基因作为肺腺癌的分子特征。
Am J Cancer Res. 2023 Mar 15;13(3):727-757. eCollection 2023.
4
Exploration of the Potential Link, Hub Genes, and Potential Drugs for Coronavirus Disease 2019 and Lung Cancer Based on Bioinformatics Analysis.基于生物信息学分析探索2019冠状病毒病与肺癌之间的潜在联系、核心基因及潜在药物
J Oncol. 2022 Sep 26;2022:8124673. doi: 10.1155/2022/8124673. eCollection 2022.
5
Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis.两种预测非小细胞肺癌骨转移患者总生存期和癌症特异性生存期的新型列线图的构建与验证
Int J Gen Med. 2021 Dec 2;14:9261-9272. doi: 10.2147/IJGM.S342596. eCollection 2021.
6
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.通过综合分析鉴定血管性血友病因子作为肺腺癌的一种新型生物标志物
Front Oncol. 2021 Apr 22;11:639600. doi: 10.3389/fonc.2021.639600. eCollection 2021.
生物信息学分析揭示TOP2A在非小细胞肺癌中的预后意义。
Cancer Cell Int. 2019 Sep 11;19:239. doi: 10.1186/s12935-019-0956-1. eCollection 2019.
4
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.一项通过机器学习策略确定肺腺癌新预后预测模型的大型队列研究。
BMC Cancer. 2019 Sep 5;19(1):886. doi: 10.1186/s12885-019-6101-7.
5
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.局部晚期和转移性非小细胞肺癌的系统治疗:综述。
JAMA. 2019 Aug 27;322(8):764-774. doi: 10.1001/jama.2019.11058.
6
Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection.非小细胞肺癌根治性切除术后10年以上的超晚期复发
Cancer Manag Res. 2019 Jul 19;11:6765-6774. doi: 10.2147/CMAR.S213553. eCollection 2019.
7
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.非小细胞肺癌:流行病学、筛查、诊断和治疗。
Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013.
8
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).利用循环肿瘤 DNA(ctDNA)高通量靶向 DNA 甲基化测序进行早期肺癌的无创诊断。
Theranostics. 2019 Apr 6;9(7):2056-2070. doi: 10.7150/thno.28119. eCollection 2019.
9
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
10
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.通过 GEO 和 TCGA 数据的综合分析,揭示肺鳞癌的转录组和功能网络特征。
Sci Rep. 2018 Oct 26;8(1):15834. doi: 10.1038/s41598-018-34160-w.